The October issue is live https://t.co/uEGWhO2B55
The cover shows perturbations that convert stem-like, atypical teratoid rhabdoid tumor (AT/RT) cells into a more differentiated, neuron-like state https://t.co/KcjY604fNf
Attend the Second Annual International Brain & Spine Tumor Symposium to learn from national and international experts, at NJ's only NCI-designated
Comprehensive Cancer Center.
https://t.co/y5ACb39V7O
Pleased to share the beta release of Signac v2 today. This release makes some important changes, including support for BPCells matrices for large-scale analysis. Documentation can be found here: https://t.co/VAYTJX05h4
Delighted to share new work from our lab: CRISPR fusion proteins to boost PRECISE genome editing (TruEditors).
We wondered what if we could “turn on” and test every gene in the human genome to accelerate protein design?
Pleased to share CRISPore-seq, which expands single-cell CRISPR screens to isoform resolution using long-read sequencing. Grateful to @nevillesanjana and my co-lead authors @drsimonmueller, @nathan__andrews, and @akashsookdeo100, whose foundational work made this possible.
Looking for some Thanksgiving reading? 🦃🦃🦃
🚨Check out our new preprint on CRISPore-seq!🚨
Combining pooled CRISPR perturbations with single-cell sequencing has been tremendously powerful... but we are missing a lot with current approaches like Perturb-seq and ECCITE-seq.
The October issue is live https://t.co/uEGWhO2B55
The cover shows perturbations that convert stem-like, atypical teratoid rhabdoid tumor (AT/RT) cells into a more differentiated, neuron-like state https://t.co/KcjY604fNf
The October issue is live https://t.co/uEGWhO2B55
The cover shows perturbations that convert stem-like, atypical teratoid rhabdoid tumor (AT/RT) cells into a more differentiated, neuron-like state https://t.co/KcjY604fNf
Delighted to share new work from our lab:
MultiPerturb-seq 🎛️❌📥📤
Over the last few years, we've been combining CRISPR screens with multimodal readouts of gene expression (RNA) and chromatin accessibility (DNA). In this study, we bring those together within the same cells.
In vivo CRISPR screens offer a unique way to study gene function at scale🐁. In our new @NatureRevGenet article, Alessio Strano, @randall_platt, and I review current methods, experimental designs, and explore exciting future directions!https://t.co/L1HGdoEgks
@ETH_en@ETH_BSSE
High-throughput #singlecell#CRISPR screens are unlocking #cancer drug targets + gene mutation functions. Read more in our blog, and learn how GEM-X Flex Gene Expression can make scalable CRISPR screens more accessible than ever: https://t.co/a9axvyhN0L
Thanks @meburkard for stopping by my poster today at #AACR25
Forever grateful for your mentorship.
Iowa is very lucky to have recruited you to direct their cancer center.
@UWMSTP
Delighted to have our Perturb-multiome paper, led by @jmartinrufino and #AlexisCaulier from our lab, published today in @ScienceMagazine. Please check out this powerful approach to decipher gene regulatory networks enriched for genetic variation: https://t.co/TOhYCqOvO1
We're incredibly excited to share our new method, Paired-Damage-seq, out @naturemethods today! This technique allows us to jointly analyze oxidative DNA damage and SSBs with RNA, all at the single-cell level (1/5). https://t.co/epPZuVC1jA
Phenomenal day of learning and networking at our 3rd annual @TJUHNeurosurg Bootcamp! Such a great time welcoming over 40 students from 20+ institutions 🧠
🧬 We’re excited to introduce D&D-seq, a single-cell technology that maps DNA:Protein interactions through molecular footprinting.. Check it out here: https://t.co/mfsDO3kKa0 #Genomics#Epigenetics